TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)
$9.7 0 (0%)
Analysed TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) News Sources
FDA Accepts NDA for TLX101-Px (Pixclara®)
09-04-2026
yahoo.com
Telix Strengthens Board with Additional Director Appointments
08-04-2026
yahoo.com
Top European Dividend Stocks To Consider For Your Portfolio
07-04-2026
yahoo.com
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
06-04-2026
yahoo.com
Telix Appoints David Gill as Non-Executive Director
01-04-2026
yahoo.com
ASX Growth Companies With Insider Ownership Up To 38%
26-03-2026
yahoo.com
Telix Pharmaceuticals Eyes 2026 Revenue Near $970M, Highlights PSMA Imaging Growth and Phase III Catalysts
22-03-2026
marketbeat.com
Telix Advances Radiopharma Platform With Key Trials And US Manufacturing Shift
21-03-2026
yahoo.com
What Powers BWXT's Strength in Nuclear Medicine Manufacturing?
20-03-2026
yahoo.com
Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.
20-03-2026
yahoo.com
What is the current price of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)?
The current price of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) is $9.7.
TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) since the previous trading day is $0.
TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)?
The most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)?
The most recent sentiment for TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS) is .
SEC-8K** Filing Available For TELIX PHARMACEUTICALS LTD (TLPPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.